BioSpace News Archive

Press Releases

Rectify Pharmaceuticals to Present New Preclinical Data at The American Association for the Study of Liver Diseases Annual Meeting

October 17, 2024
·
2 min read
Press Releases

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

October 17, 2024
·
7 min read
Press Releases

U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson’s Disease

October 17, 2024
·
12 min read
News

Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310

October 17, 2024
·
1 min read
Drug Development

IGC Pharma Announces Patient Enrollment at Toronto’s Baycrest in Phase 2 Trial Investigating IGC-AD1

October 17, 2024
·
5 min read
Drug Development

Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update

October 17, 2024
·
5 min read
Press Releases

Rapafusyn Pharmaceuticals to Present In Vivo Data on ENT1 Inhibitor for Acute Kidney injury at the American Society for Nephrology (ASN Kidney Week 2024)

October 17, 2024
·
1 min read
FDA

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

October 17, 2024
·
11 min read
Drug Development

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

October 17, 2024
·
4 min read
Drug Development

Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder

October 17, 2024
·
6 min read